Hanmi Pharmaceutical (KRX:128940) disposed of 11,180 common treasury shares to employees and officers on August 4 at the prior day's close of ₩345,500, for a total of ₩3.86 billion, transferred directly into recipients' brokerage accounts via Shinhan Investment. The filing's own reconciliation table flags the outcome as "inconsistent" with what the company originally scheduled: 10,402 shares planned versus 11,180 actually distributed, a gap the filing attributes to share-price movement and performance-evaluation results between the board's disposal decision and the actual settlement date. Separately, the filing notes Hanmi holds another 110,700 treasury shares acquired for a specific statutory purpose that are excluded from this table entirely.